<DOC>
	<DOC>NCT01931683</DOC>
	<brief_summary>The investigators attempted to determine the optimal effect-site concentration of remifentanil for smooth removal of the LMA from propofol anesthesia.</brief_summary>
	<brief_title>Dosing Study of Remifentanil for Smooth Removal of the Laryngeal Mask Airway (LMA)</brief_title>
	<detailed_description>At the end of the surgery, propofol infusion was stopped and remifentanil was titrated to predetermined (initial concentration 1.0 ng/ml for the first patient). LMA removal was performed when the patients opened their eyes and spontaneous respiration and adequate tidal volume and ventilatory frequency were confirmed.</detailed_description>
	<mesh_term>Propofol</mesh_term>
	<mesh_term>Remifentanil</mesh_term>
	<criteria>ASA III patients undergoing general anesthesia for short elective surgery (&lt;1 hr) GE reflux obesity (BMI&gt;30) anticipated difficult airway</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>LMA removal</keyword>
	<keyword>remifentanil</keyword>
	<keyword>propofol</keyword>
</DOC>